Redx shares soar after IPF drug licence deal with AstraZenec...

Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to AstraZeneca.

Study puts Jardiance in hot pursuit of AZ’s Farxiga in heart...

The FDA’s approval of AstraZeneca’s SGLT2 inhibitor Farxiga in heart failure was a first for the class, but Boehringer Ingelheim and Eli Lilly are closing the gap with a positi

Boehringer launches open innovation project for work-at-home...

Germany’s Boehringer Ingelheim is to make a bank of its molecules available to scientists in a bid to encourage open innovation during the COVID-19 pandemic, when many scientists are workin

BI opens second branch of digital lab in China

Boehringer Ingelheim has announced that it will open a second branch of its digital lab, BI X, in July this year in China.

FDA fast-tracks Lilly/Boehringer’s Jardiance in chronic kidn...

Boehringer launches digital platform to raise awareness abou...

Boehringer Ingelheim and Carebox Healthcare Solutions have launched a digital platform aimed at giving patients, families, caregivers and doctors the opportunity to learn ab